US Stock MarketDetailed Quotes

RARE Ultragenyx Pharmaceutical

Watchlist
  • 46.690
  • -0.130-0.28%
Close Mar 28 16:00 ET
  • 46.000
  • -0.690-1.48%
Post 16:05 ET
3.84BMarket Cap-5659P/E (TTM)

About Ultragenyx Pharmaceutical Company

Ultragenyx Pharmaceutical, Inc. engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010, and is headquartered in Novato, CA.

Company Profile

SymbolRARE
Company NameUltragenyx Pharmaceutical
Listing Date01/31/2014
Issue Price21.00
Founded2010
CEODr. Emil D. Kakkis, M.D.,PhD
MarketNASDAQ
Employees1276
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address60 Leveroni Court
CityNovato
ProvinceCalifornia
CountryUnited States of America
Zip Code94949
Phone1-415-483-8800

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Emil D. Kakkis, M.D.,PhD
  • Director, President, Chief Executive Officer
  • 12.14M
  • Thomas R. Kassberg
  • Chief Business Officer and Executive Vice President
  • 2.33M
  • Dr. Camille L. Bedrosian,M.D.
  • Chief Medical Officer and Executive Vice President
  • 3.76M
  • Theodore A. Huizenga
  • Senior Vice President, Corporate Controller and Chief Accounting Officer
  • --
  • Karah Parschauer
  • Chief Legal Officer and Executive Vice President
  • --
  • Dennis Karl Huang
  • Chief Technical Operations Officer and Executive Vice President, Gene Therapy Operations
  • --
  • John Richard Pinion, II
  • Chief Quality Officer and Executive Vice President, Translational Sciences
  • 3.71M
  • Dr. Eric Crombez, M.D.
  • Executive Vice President and Chief Medical Officer
  • --
  • Erik Harris
  • Chief Commercial Officer and Executive Vice President
  • 3.75M
  • Howard Horn
  • Chief Financial Officer and Executive Vice President, Corporate Strategy
  • --
  • Daniel G. Welch
  • Chairman of the Board
  • 499.44K
  • Dr. Deborah L. Dunsire,M.D.
  • Independent Director
  • 462.19K
  • Matthew K. Fust
  • Independent Director
  • 478.19K
  • Michael A. Narachi
  • Independent Director
  • 481.31K
  • Dr. Shehnaaz Suliman, M.D.
  • Independent Director
  • 466.44K
  • Dr. Corsee Dating Sanders, PhD
  • Independent Director
  • 465.81K
  • Dr. Amrit Ray
  • Independent Director
  • 1.24M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg